Source comparison
Tolerance to BPC-157 Cycling: Research Comparison
The table below compares three primary cycling strategies used in preclinical BPC-157 research, evaluating administration structure, receptor recovery dynamics, and practical application suitability. Block Cycling (4/2) 4 weeks continuous administration, 2 wee
This comparison does not assign a generated winner or score.
- The table below compares three primary cycling strategies used in preclinical BPC-157 research, evaluating administration structure, receptor recovery dynamics, and practical application suitability.
- Block Cycling (4/2)
- 4 weeks continuous administration, 2 weeks complete washout
- 85–90% receptor density restoration after 14-day washout
- Acute injury models, tendon/ligament repair, short-to-moderate research timelines (8–16 weeks total)
- Moderate—requires strict adherence to defined on/off windows
- Gold standard for most applications; strongest evidence base for efficacy preservation
- Extended Block Cycling (6/3)
- 6 weeks continuous administration, 3 weeks complete washout
- >90% receptor density restoration after 21-day washout
- Severe injuries requiring extended initial healing period, gastric ulcer models, applications where shorter on-cycles are insufficient
- Moderate-high—longer washouts increase risk of outcome regression during off-period
- Preferred when initial injury severity requires uninterrupted 6-week exposure; washout must be closely monitored
- Pulsed Microcycle (5/2)
- 5 days on, 2 days off, repeated continuously without extended washout
- Partial receptor recycling (estimated 40–60% during 48-hour breaks)
- Chronic conditions requiring 3+ month management, applications where complete washout is impractical
- Low—simple weekly pattern, easier adherence over extended periods
- Emerging protocol with limited comparative data; appears to maintain 75–85% of block cycling efficacy while eliminating extended off-periods